Genomic analysis of paired tumor–normal samples and clinical data can be used to match
patients to cancer therapies or clinical trials. We analyzed 500 patient samples across diverse …

Recent molecular studies of spitzoid neoplasms have identified mutually exclusive kinase
fusions involving ROS1, ALK, RET, BRAF, NTRK1, MET, and NTRK3 as early initiating …

We developed and clinically validated a hybrid capture next generation sequencing assay
to detect somatic alterations and microsatellite instability in solid tumors and hematologic …

Purpose: Liquid biopsy provides a real-time assessment of metastatic breast cancer (MBC).
We evaluated the utility of combining circulating tumor cells (CTC) and circulating tumor …

Stage T1 bladder cancers have the highest progression and recurrence rates of all non–muscle-invasive
bladder cancers (NMIBCs). Most T1 cancers are treated with bacillus Calmette-…

Fibroblast growth factor receptors (FGFR) are transmembrane kinase proteins with growing
importance in cancer biology given the frequency of molecular alterations and vast interface …

The clinical significance of the tumor‐immune interaction in breast cancer is now established,
and tumor‐infiltrating lymphocytes (TILs) have emerged as predictive and prognostic …

Mutations of the BRCA1 or BRCA2 gene (BRCA1/2) confer an increased lifetime risk of
developing breast, ovarian, pancreatic, and prostate cancers, among others. 1, 2 BRCA1/2-…

Modern histologic imaging platforms coupled with machine learning methods have
provided new opportunities to map the spatial distribution of immune cells in the tumor …

Heregulins (HRGs) bind to the receptors HER3 or HER4, induce receptor dimerization, and
trigger downstream signaling that leads to tumor progression and resistance to targeted …